Illumina VenturesFirm match from fund name (lower confidence)
Illumina Innovation Fund III, L.P.
Open: first sale Aug 2024, per Form D (fund age approximates vintage)
- Vintage
- 2024
- Fund size
- $60M to $200M (Form D)
- Stages
- Not stated
- Sectors
- Life sciences and research tools, Biotech, Digital health, Agtech, Synthetic biology
- Regions
- Not stated
01 · Thesis
Illumina Ventures is a genomics and precision health venture firm backing early-stage companies to improve human health. It invests across life sciences tools, diagnostics, therapeutics, digital health, and sustainability, including gene editing, cell and gene therapies, single cell analysis, and agricultural biotechnology.Inferred from the firm's website
02 · Initial check
$600K to $3.33M (estimated from fund size)
Estimated from Form D: $60M sold of a $200M target
03 · Who to approach
Named on this fund's Form D
- Nick Naclerio, Ph.D., Founding Partner
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideIllumina Ventures is a genomics and precision health investor backing early-stage companies to improve human health.
Illumina Ventures is the leader in genomics and precision health investing.
https://www.illuminaventures.com/
06 · Sources
Last verified: Oct 28, 2026